Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
Authors
Keywords
-
Journal
ONCOGENE
Volume 40, Issue 24, Pages 4079-4093
Publisher
Springer Science and Business Media LLC
Online
2021-06-02
DOI
10.1038/s41388-021-01841-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- Discovery and Optimization of Small Molecules Targeting the Protein–Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer
- (2020) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identifying drug targets in tissues and whole blood with thermal-shift profiling
- (2020) Jessica Perrin et al. NATURE BIOTECHNOLOGY
- A drug discovery platform to identify compounds that inhibit EGFR triple mutants
- (2020) Punit Saraon et al. Nature Chemical Biology
- Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
- (2020) Alexander Drilon et al. NATURE MEDICINE
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Bioluminescence resonance energy transfer–based imaging of protein–protein interactions in living cells
- (2019) Hiroyuki Kobayashi et al. Nature Protocols
- Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing
- (2019) Elsenoor Klaver et al. Disease Models & Mechanisms
- Single and dual targeting of mutant EGFR with an allosteric inhibitor
- (2019) Ciric To et al. Cancer Discovery
- Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-mediated Targeted Protein Degradation
- (2019) George M Burslem et al. CANCER RESEARCH
- Targeted protein degradation: elements of PROTAC design
- (2019) Stacey-Lynn Paiva et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Dynamin inhibitors impair platelet-derived growth factor β-receptor dimerization and signaling
- (2019) Johan Heldin et al. EXPERIMENTAL CELL RESEARCH
- The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
- (2019) Stephen P. Ducray et al. Cancers
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation
- (2019) Mahlet Z. Tamirat et al. PLoS One
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Functional recruitment of dynamin requires multimeric interactions for efficient endocytosis
- (2019) Morgane Rosendale et al. Nature Communications
- Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045
- (2018) Peng Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reactivation of mutant-EGFR degradation through clathrin inhibition overcomes resistance to EGFR tyrosine kinase inhibitors.
- (2018) Ludovic Ménard et al. CANCER RESEARCH
- Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
- (2018) Cecilia Lopez Sambrooks et al. CANCER RESEARCH
- Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
- (2018) Mikhail M. Savitski et al. CELL
- Oligosaccharyltransferase inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
- (2018) Marta Baro et al. CLINICAL CANCER RESEARCH
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs
- (2018) Leigh A. Stoddart et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift
- (2018) Melanie L. Dart et al. ACS Medicinal Chemistry Letters
- Enhancing Antiproliferative Activity and Selectivity of a FLT-3 Inhibitor by Proteolysis Targeting Chimera Conversion
- (2018) George M. Burslem et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
- (2018) Philipp M. Cromm et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Fibroblast growth factor receptors as treatment targets in clinical oncology
- (2018) Masaru Katoh Nature Reviews Clinical Oncology
- Systematic Identification of Oncogenic EGFR Interaction Partners
- (2017) Julia Petschnigg et al. JOURNAL OF MOLECULAR BIOLOGY
- Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
- (2017) Qian Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome
- (2017) Zhong Yao et al. MOLECULAR CELL
- Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
- (2017) Yoshimi Ohashi et al. Oncotarget
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
- (2016) Scott A. Foster et al. CANCER CELL
- M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
- (2016) Yoshimi Ohashi et al. CANCER RESEARCH
- Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
- (2016) Christopher J. Tape et al. CELL
- Signal processing by the endosomal system
- (2016) Roberto Villaseñor et al. CURRENT OPINION IN CELL BIOLOGY
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- (2016) Ying-Nan P. Chen et al. NATURE
- Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
- (2016) Yong Jia et al. NATURE
- Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells
- (2016) Cecilia Lopez-Sambrooks et al. Nature Chemical Biology
- Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
- (2016) NATURE MEDICINE
- The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
- (2016) Abdulraheem Alshareef et al. Scientific Reports
- NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions
- (2015) Thomas Machleidt et al. ACS Chemical Biology
- Insulin/receptor binding: The last piece of the puzzle?
- (2015) Pierre De Meyts BIOESSAYS
- Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma
- (2015) H. Cheng et al. CANCER RESEARCH
- Insulator dysfunction and oncogene activation in IDH mutant gliomas
- (2015) William A. Flavahan et al. NATURE
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes
- (2015) Roberto Villaseñor et al. eLife
- Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation
- (2014) Jennifer L. Macdonald-Obermann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells
- (2014) Julia Petschnigg et al. NATURE METHODS
- Synthesis of the Pitstop family of clathrin inhibitors
- (2014) Mark J Robertson et al. Nature Protocols
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Tracking cancer drugs in living cells by thermal profiling of the proteome
- (2014) M. M. Savitski et al. SCIENCE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
- (2013) Hui K. Gan et al. FEBS Journal
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- Endocytosis and Cancer
- (2013) I. Mellman et al. Cold Spring Harbor Perspectives in Biology
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
- (2012) Alex Kentsis et al. NATURE MEDICINE
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth
- (2012) Fred Harbinski et al. Cancer Discovery
- Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition
- (2011) Lisa von Kleist et al. CELL
- Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R
- (2011) Kerrington R. Molhoek et al. MELANOMA RESEARCH
- A direct role for Met endocytosis in tumorigenesis
- (2011) Carine Joffre et al. NATURE CELL BIOLOGY
- A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
- (2011) Carla Lucia Esposito et al. PLoS One
- COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport
- (2010) Ying-Nai Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy
- (2010) J. N. Contessa et al. CLINICAL CANCER RESEARCH
- Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@
- (2009) Byung Chung et al. BMC CELL BIOLOGY
- Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
- (2009) L. M. Sholl et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
- (2009) Chunaram Choudhary et al. MOLECULAR CELL
- Endocytosis and signalling: intertwining molecular networks
- (2009) Alexander Sorkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells
- (2008) J. N. Contessa et al. CANCER RESEARCH
- Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
- (2008) S. Yano et al. CANCER RESEARCH
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
- The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
- (2007) Marie Dance et al. CELLULAR SIGNALLING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now